Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

"My Decision" Tubal Sterilization Decision Support Tool

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04097717
Recruitment Status : Not yet recruiting
First Posted : September 20, 2019
Last Update Posted : October 18, 2019
Sponsor:
Collaborators:
University of Tennessee
University of California, San Francisco
National Institute on Minority Health and Health Disparities (NIMHD)
Information provided by (Responsible Party):
Sonya Borrero, University of Pittsburgh

Brief Summary:
This study seeks to test a web-based decision support tool developed to enhance low-income women's ability to make informed decisions about tubal sterilization that align with their preferences, values and reproductive goals. Half of participants will receive usual care, while the other half will use the web-based decision aid plus usual care. The investigators hypothesize that compared to women who receive usual care alone, women randomized to the decision aid arm will have greater knowledge about sterilization and alternative options, lower decisional conflict, and will be more satisfied with their contraceptive decision at 3-month follow-up.

Condition or disease Intervention/treatment Phase
Tubal Sterilization Women's Health Contraception Contraception Behavior Reproductive Behavior Behavioral: "My Decision" tubal sterilization decision aid Other: Usual Care Not Applicable

Detailed Description:

Female surgical sterilization is the second most commonly used contraceptive method in the US and is disproportionately used by low-income women and women of color. Whether the higher use of sterilization in these populations reflects inappropriate overutilization is unclear. On one hand, low-income and racial minority women frequently misunderstand the permanent nature of sterilization, are often unaware of reversible contraceptive alternatives, and commonly experience regret after the procedure- suggesting suboptimal decision making. On the other hand, there is evidence of substantial unmet demand for sterilization among low-income women, due to unique access barriers posed by Medicaid sterilization regulations, putting them at high risk for unintended pregnancy and the adverse health and social consequences associated with unintended pregnancy.

Medicaid sterilization policy currently requires that all women requesting a federally-funded procedure complete a standardized consent form at least 30 days prior to sterilization. This policy was originally instituted in the 1970s to protect vulnerable women from coercive sterilization practices by attempting to ensure informed and voluntary consent. However, there is growing consensus that the policy is incapable of ensuring informed consent, and that the mandatory 30-waiting period impedes access to desired sterilization for many low-income women. The lack of a process that can ensure both informed consent and timely access for sterilization procedures hampers progress toward reproductive health equity for low-income women.

This study seeks to test a novel, web-based decision support tool to support low-income women's ability to make informed and value-concordant decisions about surgical sterilization. A decision support tool may be particularly useful in the context of sterilization decisions because this is a preference-sensitive decision with permanent implications and because there is a high level of misunderstanding about sterilization and limited awareness of alternative options among women who have undergone the surgery, indicating critical gaps in the quality of pre-sterilization counseling. Furthermore, patient-provider interactions may be complicated by a broader social and historical context in which poor and minority women's reproductive choices have not always been valued.

The study is a multi-site randomized controlled trial to test the effect of the decision aid plus usual care compared to usual care alone on decision quality among 350 racially-diverse, low-income pregnant women considering a post-partum sterilization procedure. Participant surveys will be utilized at three assessments points to evaluate outcomes.

In addition to its potential clinical utility, this research also has important policy implications, as it can inform ongoing efforts to transform the current Medicaid policy by offering a decision aid that is able to ensure informed decision making in vulnerable populations, thereby allowing the investigators to ultimately replace the current Medicaid consent form with this scalable tool. Once there is a tool to safeguard women with an evidence-based process for ensuring informed consent, further progress can be made in potentially shortening or waiving the mandatory 30-day waiting period that has restricted access to desired sterilization for many low-income women.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 350 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: This study is a randomized controlled trial in which participants will be assigned to one of two groups (intervention arm or usual care arm) in parallel for the duration of the study. All participants will be asked to complete assessments at three separate time points [immediately after using the decision aid (for those in the intervention arm) when participants are less than 24 weeks gestation (Time 1); in the 3rd trimester between 32-36 weeks gestation (Time 2); and three months postpartum (Time 3)].
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Developing and Testing a Decision Support Tool for Women Making Tubal Sterilization Decisions
Estimated Study Start Date : October 2019
Estimated Primary Completion Date : August 31, 2022
Estimated Study Completion Date : August 31, 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Tubal Ligation

Arm Intervention/treatment
Experimental: Decision Aid Arm
Participants will use the web-based decision aid plus usual medical care.
Behavioral: "My Decision" tubal sterilization decision aid
The "My Decision" tubal sterilization decision aid is a web-based decision aid designed to help women make informed decisions about tubal sterilization.

Other: Usual Care
Usual medical care will vary among participants.

Usual Care Arm
Participants will receive usual medical care.
Other: Usual Care
Usual medical care will vary among participants.




Primary Outcome Measures :
  1. Participant Knowledge about Tubal Sterilization [ Time Frame: Less than 24 weeks gestation (Time 1) ]
    Participant responses to 10 True/False items adapted from previously published studies of tubal sterilization knowledge and informed by in-depth interviews with women about sterilization decision making. Items assess knowledge about tubal sterilization and alternative contraception options and will be coded as correct vs. incorrect, with "Don't Know" being coded as an incorrect response. The percentage of correct responses across the 10 questions will be calculated for each participant. The score range is 0 to 100%.

  2. Participant Decisional Conflict in Postpartum Contraceptive Choice [ Time Frame: Less than 24 weeks gestation (Time 1) ]
    Assessed by participant responses to the low literacy version of the Decisional Conflict Scale (DCS). The DCS is a validated measure to assess participants' decisional conflict in medical decision-making. The DCS low literacy version includes 10 items about experience of conflict, with "Yes" = 0, "unsure" = 2 and "No" = 4. All 10 items are a) summed; b) divided by 10; and c) multiplied by 25. Scores range from 0 (no decisional conflict) to 100 (extremely high decisional conflict).


Secondary Outcome Measures :
  1. Contraceptive Method Selected [ Time Frame: Less than 24 weeks gestation (Time 1) ]
    Will determine the proportion of women who select sterilization versus another method of contraception at Time 1. Assessed by participant responses to an item asking which contraceptive method they are planning to use after delivery.

  2. Participant Satisfaction with Decision Making [ Time Frame: Three months postpartum (Time 3) ]
    Assessed by participant responses to the Satisfaction with Decision Scale (SWD), a validated 6-item scale measuring participants' satisfaction with healthcare decision making. The SWD uses a 5-point Likert scale where 1 is "Strongly Disagree" and 5 is "Strongly Agree." A summary score is calculated as an average of all items with a range of 1-5, with a higher score reflecting a higher level of satisfaction with the decision.


Other Outcome Measures:
  1. Participant Knowledge about Tubal Sterilization [ Time Frame: 32-36 weeks gestation (Time 2) ]
    Participant responses to 10 True/False items adapted from previously published studies of tubal sterilization knowledge and informed by in-depth interviews with women about sterilization decision making. Items assess knowledge about tubal sterilization and alternative contraception options and will be coded as correct vs. incorrect, with "Don't Know" being coded as an incorrect response. The percentage of correct responses across the 10 questions will be calculated for each participant. The score range is 0 to 100%. Participant knowledge will be measured at Time 2 to assess the sustained impact of the decision aid on knowledge.

  2. Participant Decisional Conflict in Postpartum Contraceptive Choice [ Time Frame: 32-36 weeks gestation (Time 2) ]
    Assessed by participant responses to the low literacy version of the Decisional Conflict Scale (DCS). The DCS is a validated measure to assess participants' decisional conflict in medical decision-making. The DCS low literacy version includes 10 items about experience of conflict, with "Yes" = 0, "unsure" = 2 and "No" = 4. All 10 items are a) summed; b) divided by 10; and c) multiplied by 25. Scores range from 0 (no decisional conflict) to 100 (extremely high decisional conflict). Decisional conflict will be measured at Time 2 to assess the sustained impact of the decision aid on decisional conflict.

  3. Contraceptive Method Selected [ Time Frame: 32-36 weeks gestation (Time 2) ]
    Will determine the proportion of women who select sterilization versus another method of contraception at Time 2. Assessed by participant responses to an item asking which contraceptive method they are planning to use after delivery.

  4. Contraceptive Method(s) Used [ Time Frame: Three months postpartum (Time 3) ]
    Assessed by participant responses to a multiple choice item asking which methods of contraception they have used or received since their pregnancy ended.

  5. Ease in Contraceptive Decision Making [ Time Frame: Less than 24 weeks gestation (Time 1) ]
    Assessed by participant responses to a 10 point scale about ease of decision making with regards to contraceptive method selection. Response options range from 0 ("Strongly Disagree" that this is an easy decision to make) to 10 ("Strongly Agree" that this an easy decision to make").

  6. Ease in Contraceptive Decision Making [ Time Frame: 32-36 weeks gestation (Time 2) ]
    Assessed by participant responses to a 10 point scale about ease of decision making with regards to contraceptive method selection. Response options range from 0 ("Strongly Disagree" that this is an easy decision to make) to 10 ("Strongly Agree" that this an easy decision to make").

  7. Certainty about Tubal Sterilization Decision [ Time Frame: Less than 24 weeks gestation (Time 1) ]
    Assessed by participant responses to a 10 point scale indicating certainty in desire to obtain or not obtain a tubal sterilization. Response options range from 0 ("Very Certain that I Do Not Want") to 10 ("Very Certain that I Do Want").

  8. Certainty about Tubal Sterilization Decision [ Time Frame: 32-36 weeks gestation (Time 2) ]
    Assessed by participant responses to a 10 point scale indicating certainty in desire to obtain or not obtain a tubal sterilization. Response options range from 0 ("Very Certain that I Do Not Want") to 10 ("Very Certain that I Do Want").

  9. Participant Satisfaction with Current Contraceptive Method(s) [ Time Frame: Three months postpartum (Time 3) ]
    Assessed by participant responses to a 5-point Likert scale regarding satisfaction with current contraceptive method(s). Response options range from 1 ("Very Unsatisfied") to 5 ("Very Satisfied").

  10. Number of Pregnancies Since Delivery [ Time Frame: Three months postpartum (Time 3) ]
    Assessed by participant-reported survey responses to a Yes/No item about whether a pregnancy has occurred since delivery.

  11. Participant Satisfaction with Sterilization Counseling [ Time Frame: Three months postpartum (Time 3) ]
    Participant responses to an 8-item patient-provider communication scale created by the PI to assess participant satisfaction with the sterilization counseling experience. Response options range from 1 ("Strongly Disagree") to 5 ("Strongly Agree"). Items will be examined individually. In addition, a summary score will be created with items 2,3,6 reverse coded such that the range will be 8-40 with a higher score reflecting greater satisfaction with sterilization counseling.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Male and Trans Male participants will not be eligible for participation in this study.
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Pregnant women
  • 21-45 years of age
  • Fluently speak English or Spanish
  • Fluently read English or Spanish
  • Considering tubal sterilization
  • < 24 weeks gestation
  • Continuing current pregnancy
  • Using Medicaid insurance

Exclusion Criteria:

  • Unable to consent to study participation
  • Unable to interact with the content of the web-based decision aid

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04097717


Contacts
Layout table for location contacts
Contact: Sonya Borrero, MD, MS 412-692-4841 borrsp@UPMC.edu
Contact: Kristen Rice, MPH 412-692-4317 krr78@pitt.edu

Locations
Layout table for location information
United States, California
University of California, San Francisco Not yet recruiting
San Francisco, California, United States, 94143
Contact: Christine Dehlendorf, MD, MAS    415-206-8712    Christine.Dehlendorf@uscf.edu   
Contact: Reiley Reed, MPH    415-206-2336    reiley.reed@uscf.edu   
United States, Tennessee
University of Tennessee Not yet recruiting
Knoxville, Tennessee, United States, 37920
Contact: Nikki Zite, MD, MPH    865-305-9584    nzite@utmck.edu   
Contact: Jill Maples, PhD    865-591-2894    JMaples1@utmck.edu   
Sponsors and Collaborators
University of Pittsburgh
University of Tennessee
University of California, San Francisco
National Institute on Minority Health and Health Disparities (NIMHD)
Investigators
Layout table for investigator information
Principal Investigator: Sonya Borrero, MD, MS University of Pittsburgh

Layout table for additonal information
Responsible Party: Sonya Borrero, Professor of Medicine, University of Pittsburgh
ClinicalTrials.gov Identifier: NCT04097717     History of Changes
Other Study ID Numbers: PRO19070122
R01MD011678-01 ( U.S. NIH Grant/Contract )
First Posted: September 20, 2019    Key Record Dates
Last Update Posted: October 18, 2019
Last Verified: October 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: De-identified participant data will be used for publication.
Time Frame: Publication of results will occur upon completion of the study.
Access Criteria: De-identified participant data will be used for publication.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Sonya Borrero, University of Pittsburgh:
Tubal Ligation
Decision Aid